AEF logo
abrdn Emerging Markets ex-China Fund, Inc.(AEF)
Last print unknown agoAbout this dataData status
$8.63▲0.00 (0.00%)Stale · unknown old

AEF Operating Expenses

-$196.21MTTM · USD

Period ending:

AEF FY Operating ExpensesUSD
AEF FY Operating Expenses1989-12-31: $130.00K1990-12-31: $570.00K1991-12-31: $1.46M1992-12-31: $1.70M1993-12-31: $740.00K1994-12-31: $860.00K1995-12-31: $870.00K1996-12-31: $2.49M1997-12-31: $7.91M1998-12-31: $720.00K1999-12-31: $1.71M2000-12-31: $3.56M2001-12-31: $2.37M2002-12-31: -$250.00K2003-12-31: $460.00K2004-12-31: $800.00K2005-12-31: $870.00K2006-12-31: $1.20M2007-12-31: $1.03M2008-12-31: $1.21M2009-12-31: $1.12M2010-12-31: $1.73M2011-12-31: $1.09M2012-12-31: $888.78K2013-12-31: $1.03M2014-12-31: $1.31M2015-12-31: $759.49K2016-12-31: $901.95K2017-12-31: $914.00K2018-12-31: $2.26M2019-12-31: $1.49M2020-12-31: $53.68M2021-12-31: $1.54M2022-12-31: $1.40M2023-12-31: $956.99K2024-12-31: $994.06K2025-12-31: -$67.05M$53.68M-$67.05M
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AEF operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

abrdn Emerging Markets ex-China Fund, Inc. Common Stock Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
-67,046,607
994,056
956,985
1,402,898
1,535,021
53,676,021
1,490,480
2,261,805
913,997
901,950
759,487
1,312,086
1,033,868
888,781
1,090,418
1,728,235
1,120,000
1,210,000
1,030,000
1,200,000
870,000
800,000
460,000
-250,000
2,370,000
3,560,000
1,710,000
720,000
7,910,000
2,490,000
870,000
860,000
740,000
1,700,000
1,460,000
570,000
130,000

Compare operating expenses

All AEF financial metrics · AEF stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.